Summary

Overview
The global breathalyzer and drug testing equipment market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031.
Drug testing devices are tools designed to detect the presence of drugs in various biological samples such as urine, saliva, hair, blood and sweat. They utilize the technologies such as immunoassay, chromatography etc, to detect the drug traces and levels in the human body. These devices are used for substance abuse monitoring, clinical diagnostics and forensic investigations. The breathalyzers are also the drug testing devices which measure the blood alcohol concentration (BAC) from a breath sample. They are commonly used by individuals for personal screening, law enforecment department for roadside testing, and employers for workplace safety. These breathalyzers provide quick and reliable results to ensure compliance with legal and safety standards.

Market Dynamics: Drivers
Rising road accidents under the influence of drugs
Alcohol plays a cultural and social role in many societies. However, the harmful effects of alcohol experienced in many aspects of daily life are undeniable. An extensive body of literature identifies that driving after drinking alcohol significantly raises the risk of a crash and the severity of that crash, resulting in deaths and serious injuries.
The stringent government regulations and laws to reduce driving incidences under the influence of drugs and alcohol drive the market in the forecast period. As per the World Health Organization Report 2022, road traffic injuries are a major public health problem and a foremost cause of death and injury worldwide. Every year around 1.3 million people die, and millions more are injured or disabled due to road crashes, mostly in low- and middle-income countries. As well as creating enormous social costs for individuals, families and communities, road traffic injuries heavily burden health services and economies.
In its latest reports, the WHO estimates that between 5% and 35% of global road deaths are alcohol-related. In most high-income countries, about 20% of fatally injured drivers have blood alcohol concentration levels above the legal limit. Studies in low- and middle-income countries have shown that 33% and 69% of fatally injured drivers and 8% and 29% of non-fatally injured drivers had consumed alcohol before their crashes. The rising incidences under the influence of drugs and alcohol and rising government regulations drive the market worldwide.
Moreover, technological advancements and the growing adoption of breathalyzers and drug-testing equipment are expected to drive the global breathalyzer and drug-testing equipment market.
Restraints
However, false positive/false negative results are provided by some breathalyzers due to improper calibration, incorrect chemical solutions, inappropriate modifications, faulty programming, improper methodology, electronic interference, certain health conditions, and exposure to chemicals. High cost of advanced drug tesing models may limit their usage especially in the low-to-middle income countries.
For more details on this report - Request for Sample
Segment Analysis
The global breathalyzer and drug testing equipment market is segmented based on type, usage, modality, end user and region.
The urine drug testing devices in the type segment accounted for approximately 46.2% of the global breathalyzer and drug testing equipment market share
The most commonly used drug test is the urine drug test, which uses urine as a sample for detecting the drugs or their metabolite traces in the body. This method is mostly favored due to its versatility, cost-effectiveness, and ease of usage. This test can identify recent drug use, typically within the past few days to a week making them suitable for both workplace screening and in clinical settings. Urine analysis is capable of detecting various substances such as marijuana, methamphetamine, cocaine, opioids, etc.
For instance, on September 1 2023, a cohort study published in the Elsevier Journal has stated that urine drug test (UDT) is the most commonly employed screening method for the patients who are receiving treatment for opioid use disorder (OUD) to assess substance absue and medication adherence. The study conducted in the 9 states of U.S. concluded that the proportion of urine drug test usage ranges from 62.1% to 89.8%.
On March 30, 2022, as per the finding of Quest Diagnostics drug testing index analysis in the U.S., the rate of positive drug test results among the workforce has climbed by 30% as comapred to previous decade. The study was conducted using more than 11 million drugs testing kits, among which the nearly 9 million urine test kits were utilized to collect the data. This represents the reliability of urine testing devices for substance abuse.
Geographical Analysis
North America is expected to dominate the market with a 43.8% share in the global breathalyzer and drug testing equipment market
North America dominates the breathalyzer and drug testing equipment market and is anticipated to show a parallel trend over the forecast period. An increasing number of accidents and awareness programs in the North American region drive the market.
According to the WHO report published in 2022, consuming alcohol can be an enjoyable activity for some people. However, many people may not realize the impact on the body and can impair the ability to perform routine tasks. Drinking and driving is a dangerous combination. Evidence notes that in the U.S., it is responsible for roughly 28 deaths a day, costing the U.S. approximately $44 billion annually.
In the U.S., half a million people are injured and 17,000 killed every year in drunk driving-related traffic crashes. Almost 40% of all youth road fatalities are directly related to alcohol consumption.
Using breathalyzers can help reduce the number of motor vehicle accidents involving an alcohol-impaired driver. This device estimates the concentration of alcohol in the breath to decide whether a person has drunk too much alcohol to drive safely. All these factors are driving the market in the North American region.
COVID-19 Impact Analysis
The Covid-19 pandemic significantly impacted the global breathalyzer and drug testing market in multiple ways. The imposed lockdowns restricted the movement which has led to decreased testing in the workplaces. Many businesses were shut down and many have opted for remote working which has reduced the immediate need of drug testing.
According to Monitoring the Future Survey, which examines drug and alcohol use among adolescents and young adults, found that the proportion of teenagers reporting substance use declined dramatically in 2021. The data show the highest one-year decline in total illegal drug usage since the poll began in 1975.
Market Segmentation
By Type
● Urine Drug Testing Devices
● Oral Fluid Drug Testing Devices
● Hair Drug Testing Devices
● Blood Drug Testing Devices
● Breathalyzers
- Fuel Cell Breathalyzers
- Semi-Conductor Breathalyzers
- IR-Spectroscopy Breathalyzers
- Others
● Others
By Usage
● Preliminary Alcohol Screening
● Evidential Breath Testing
● Home Testing
● Workplace Testing
● Forensic Testing
● Clinical Testing
By Modality
● Point-of-Care Testing (POCT)
● Laboratory Testing
● At-Home Test Kits
● On-Site Testing Kits
By End User
● Law Enforcement Agencies
● Hospitals & Laboratories
● Rehabilitation Centers
● Educational and Workplaces
● Others
By Region
● North America
- U.S.
- Canada
- Mexico
● Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
● South America
- Brazil
- Argentina
- Rest of South America
● Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
● Middle East and Africa
Competitive Landscape
The major players in the breathalyzer and drug testing equipment market include Abbott, Dragerwerk AG & Co. KGaA, Quest Diagnostics, BACtrack, Intoximeters, Accuquik Test Kits, Siemens Healthcare Private Limited, Roche Diagnostics Limited., C4 Development, Cannabix Technologies Inc. among others.
Why Purchase the Report?
● To visualize the global breathalyzer and drug testing equipment market segmentation based on type, usage, modality, end user and region as well as understand key commercial assets and players.
● Identify commercial opportunities by analyzing trends and co-development
● Excel data sheet with numerous data points of breathalyzer and drug testing equipment market-level with all segments.
● PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
● Product mapping available as excel consisting of key products of all the major players.
The global breathalyzer and drug testing equipment market report would provide approximately 70 tables, 71 figures, and 187 Pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Usage
3.3. Snippet by Modality
3.4. Snippet by End User
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising road accidents under the influence of drugs
4.1.1.2. Technological advancements in the drug testing equipment
4.1.2. Restraints
4.1.2.1. Inaccurate results of the equipment
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Urine Drug Testing Devices*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Oral Fluid Drug Testing Devices
7.4. Hair Drug Testing Devices
7.5. Blood Drug Testing Devices
7.6. Breathalyzers
7.6.1. Fuel Cell Breathalyzers
7.6.2. Semi-Conductor Breathalyzers
7.6.3. IR-Spectroscopy Breathalyzers
7.6.4. Others
7.7. Others
8. By Usage
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
8.1.2. Market Attractiveness Index, By Usage
8.2. Preliminary Alcohol Screening*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Evidential Breath Testing
8.4. Home Testing
8.5. Workplace Testing
8.6. Forensic Testing
8.7. Clinical Testing
9. By Modality
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
9.1.2. Market Attractiveness Index, By Modality
9.2. Point-of-Care Testing (POCT)*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Laboratory Testing
9.4. At-Home Test Kits
9.5. On-Site Testing Kits
9.6. Clinical Testing
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Law Enforcement Agencies*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Hospitals & Laboratories
10.4. Rehabilitation Centers
10.5. Educational and Workplaces
10.6. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. The U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. South Korea
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Abbott
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Drägerwerk AG & Co. KGaA
13.3. Quest Diagnostics
13.4. BACtrack
13.5. Intoximeters
13.6. Accuquik Test Kits
13.7. Siemens Healthcare Private Limited
13.8. Roche Diagnostics Limited.
13.9. C4 Development
13.10. Cannabix Technologies Inc.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us